Navigation Links
DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
Date:11/14/2013

>Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K. We do not undertake to update these forward-looking statements made by us.

For further information, please visit www.delmarpharma.com.


'/>"/>
SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)...   Ivenix Inc. , a medical technology ... on a $42M round of equity financing led ... CICA, Inc., Easterly Capital, Fidelity Biosciences, and SCP ... financing will support the company,s efforts to enter ... acted as the exclusive placement agent for the ...
(Date:9/1/2015)... , September 1, 2015 ... on the basis of sectors, products & services ... globally coupled with the increasing demand of advanced ... expected to propel the growth for bioinformatics market. ... information efficiently is known as bioinformatics. Decreasing cost ...
(Date:9/1/2015)... , Sept. 1, 2015 Within just ... SHL Group has rapidly reached 3,000 employees worldwide. ... growth in the injectable drug delivery market and ... A global leader in the design and manufacturing ... innovative designs, robust manufacturing capabilities, a lean supply ...
Breaking Medicine Technology:Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4SHL Group Reaches Major Milestone of 3000 Employees 2
... Sept. 15, 2011 Inogen has won a service ... and devices to patients in TRICARE,s 21-state western service ... the Inogen One portable oxygen concentrator to ... TRICARE West (TriWest) covers 2.7 million patients in ...
... N.J., Sept. 15, 2011 Fidia Farmaceutici S.p.A. (Fidia) ... (sodium hyaluronate), an injectable treatment for knee pain ... physical therapy are not enough, will be transferred from ... 2011.  Fidia Farmaceutici S.p.A. is the owner and manufacturer ...
Cached Medicine Technology:Inogen Awarded Contract to Service TRICARE West Oxygen Therapy Patients 2HYALGAN® (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici S.p.A. 2
(Date:9/2/2015)... ... 2015 , ... On September 9, 2015, over 27,000 people from all over ... convention to date for the state of Utah. , “We are thrilled with the ... David Stirling, doTERRA CEO. “One of the most exciting elements of our convention is ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Brain Aneurysm Awareness Month , which was established by the Foundation in ... awareness and education, and helping fund more research remains our top priority,” commented ...
(Date:9/2/2015)... ... ... Mobile working is increasingly more important, as business professionals are looking to ... are being launched, and mobile device usage as a whole is something people around ... personal lives. What's more people are expecting mobile versions of their favorite software. , ...
(Date:9/1/2015)... ... 2015 , ... September is National Prostate Cancer Awareness Month and Florida Hospital ... each year in the United States. , Prostate cancer is to men what breast ... 1 in 7 men. One new case occurs every 2.3 minutes and a man ...
(Date:9/1/2015)... ... 2015 , ... According to a study published August 25th in ... in a three year study about weight loss and diabetes were far more likely ... loss surgery at the onset of the trial. In fact, the participants in the ...
Breaking Medicine News(10 mins):Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... Veteran,s charity supports Obama administration,s announcement of plan ... system available to wounded veterans , OSSINING, N.Y., ... Salute America,s Heroes , a leading non-partisan, ... veterans returning from Iraq and Afghanistan and their ...
... FRANCISCO, April 9 Burrill & Company, a San ... principal activities in Venture Capital, Private Equity, Merchant Banking ... promotions: , Tiba Aynechi to Director, Merchant Banking ... Patel to Senior Associate, Merchant Banking Tiba Aynechi ...
... previous obesity , , THURSDAY, April 9 (HealthDay News) -- ... at increased risk for physical disabilities, even if they,ve shed ... a new U.S. study. , "In both men and women, ... developing mobility limitations in old age, and the longer they ...
... Legacy Foundation(R) and ASPCA(R) Urge Pet Owners to Safeguard Their ... April 9 The American Legacy Foundation(R) is challenging pet ... of April, which kicks off Prevention of Cruelty to Animals ... safe levels of exposure to secondhand smoke -- for humans ...
... Largest Breast Cancer Organization Investing $60 Million to Research Despite ... Testing whether a powerful ingredient in marijuana can help slow ... of six Bay Area breast cancer studies being funded this ... leader in the breast cancer movement announced today. The projects ...
... touts five of the first 23 recognized facilities.MILWAUKEE, April 9 ... is home to five breast centers out of ... Program for Breast Centers ( NAPBC ), a ... http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b )The first facility named in Wisconsin, was ...
Cached Medicine News:Health News:Coalition to Salute America's Heroes(TM) Applauds President's Announcement to Create Joint Virtual Lifetime Records 2Health News:Burrill & Company Announces Promotions 2Health News:Extra Pounds in Mid-Life Affect Later Mobility 2Health News:Tobacco is Toxic for Toto Too 2Health News:Tobacco is Toxic for Toto Too 3Health News:N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R) 2Health News:N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R) 3Health News:Aurora Health Care Breast Centers Receive National Recognition 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: